Heparin-induced thrombocytopenia

Orthopaedic Nursing

Volumn 26, Issue 6, 2007, Pages 383-385

  Unkle, David W ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; THROMBIN; VITAMIN K GROUP;

CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG MONITORING; EPIDEMIOLOGY; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LUNG EMBOLISM; PROTHROMBIN TIME; REVIEW; THROMBOCYTOPENIA; UNITED STATES; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; DRUG MONITORING; HEPARIN; HUMANS; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; PRECIPITATING FACTORS; PROTHROMBIN TIME; PULMONARY EMBOLISM; THROMBIN; THROMBOCYTOPENIA; UNITED STATES; VENOUS THROMBOEMBOLISM; VITAMIN K;

EID: 36749080433     PISSN: 07446020     EISSN: 1542538X     Source Type: Journal    
DOI: 10.1097/01.NOR.0000300952.80870.ce     Document Type: Short Survey

References (37)

1. Alikhan, R., Peters, F., Wilmott, R., & Cohen, A. T. (2004). Fatal pulmonary embolism in hospitalized patients: A necropsy review. Journal of Clinical Pathology, 57, 1254-1257.
2. Anderson, F. A., Zayaruzny, M., Heit, J. A., Fidan, D., Cohen, A. T., et al. (in press). Estimated annual numbers of U.S. acute-care hospital patients at risk for venous thromboembolism. American Journal of Hematology.
3. Baird, R. A., & Convery, R. (1977). Arterial thromboembolism in patients receiving systemic heparin therapy: A complication associated with heparin-induced thrombocytopenia. Journal of Bone and Joint Surgery, 59-A(8), 1061-1064.
4. Bartholomew, J. R., Begelman, S. M., & Almahameed, A. (2005). Heparin-induced thrombocytopenia: Principles for early recognition and management. Cleveland Clinic Journal of Medicine, 72(1), S31-S36.
5. Brieger, D. B., Mak, K. H., Kottke-Marchant, K., Kottke-Marchant, K. (1998). Heparin-induced thrombocytopenia. Journal of the American College of Cardiology, 31(7), 1449-1459.
6. Chong, B. H. (2003). Heparin-induced thrombocytopenia. Journal Thrombosis and Haemostasis, 1, 1471-1478.
7. Comerota, A. J., Chouhan, V., Harada, R. N., Sun, L., Hosking, J., Veermansunemi, R. B. A., et. al. (1997). The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis. Annals of Surgery, 226(3), 306-314.
8. Comerota, A. J., Katz, M. L., & White, J. V. (1992). Why does prophylaxis with external pneumatic compression for deep vein thrombosis fail? American Journal of Surgery, 164(3), 265.
9. Cooney, M. F. (2006). Heparin-induced thrombocytopenia: Advances in diagnosis and treatment. Critical Care Nurse, 26(6), 30-36.
10. Das, P., Ziada, K., Steinhubl, S. R., et al. (2006). Heparin-induced thrombocytopenia and cardiovascular diseases. American Heart Journal, 152(1), 19-26.
11. Geerts, W. H., Pineo, G. F., Heit, J. A., Bergquist, D., Lassen, M. R., Colwell, C. W., et al. (2004). Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombic and Thrombolytic Therapy. Chest, 126(3 suppl), 338S-400S.
12. Goldhaber, S. Z. (in press). Venous thromboembolism risk among hospitalized patients: Magnitude of risk is staggering. American Journal of Hematology.
13. Howell, W. H., & Holt, E. (1918). Two new factors in blood coagulation-heparin and pro-antithrombin. American Journal of Physiology, 47(3), 328-341.
14. Jacobs, D. G., Piotrowski, J. J., Hoppensteadt, D. A., Salvator, A. E., Fareed, J. (1996). Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: Preliminary results. Journal of Trauma, 40(5), 710-717.
15. Jang, I. K., & Hursting, M. J. (2005). When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation, 111(20), 2671-2683.
16. Kamm, R. D. (1982). Bioengineering studies of periodic external compression as prophylaxis against deep vein thrombosis - Part I. Journal of Biomechanical Engineering, 104(2), 87-95.
17. Kelton, J. G. (2005). The pathophysiology of heparin-induced thrombocytopenia: Biological basis for treatment. Chest, 127(2 suppl), 9S-20S.
18. Kessler, C. M., Hirsch, D. R., Jacobs, H., MacDougall, R., Goldhaber, S. Z. (1996). Intermittent pneumatic compression in chronic venous insufficiency favorably effects fibrinolytic potential and platelet activation. Blood, Coagulation, Fibrinolysis, 7(4), 437-446.
19. Kuntz, J. G., Cheesman, J. D., & Powers, R. D. (2006). Acute thrombotic disorders. American Journal of Emergency Medicine, 24(2), 460-467.
20. Levine, R. L. (2005) Finding haystacks full of needles: From Opus to Osler. Chest, 127(5), 1488-490.
21. Levy, J. H., & Hursting, M. J. (2007). Heparin-induced thrombocytopenia: A prothrombic disease. Hematology Oncology Clinics of North America, 21, 65-88.
22. Levy, J. H., Tanaka, K. A., & Hursting, M. J. (2007). Reducing thrombotic complications in the perioperative setting: An update on heparin-induced thrombocytopenia. Anesthesia & Analgesia, 105(3), 570-582.
23. MacLellan, D. G., & Fletcher, J. P. (2007). Mechanical compression in the prophylaxis of venous thromboembolism. ANZ Journal of Surgery, 77(3), 418-423.
24. Napolitano, L. M., Warkentin, T. E., Almahameed, A., Nasraway, S. A. (2006). Heparin-induced thrombocytopenia in the critical care setting: Diagnosis and management. Critical Care Medicine, 34(12), 2898-2911.
25. Nutescu, E. A., Shapiro, N. L., & Chevalier, A. (2006). New anticoagulant agents: Direct thrombin inhibitors. Clinical Geriatric Medicine, 22, 33-56.
26. Rice, L. (2004). Heparin-induced thrombocytopenia: Myths and misconceptions that will cause trouble for you and your patient. Archives of Internal Medicine, 164(18), 1961-1964.
27. Selleng, K., Warkentin, T. E., & Greinacher, A. (2007). Heparin-induced thrombocytopenia in intensive care patients. Critical Care Medicine, 35(4), 1165-1176.
28. Silver, D., Kapsch, D. N., & Tsoi, E. K. M. (1983). Heparin-induced thrombocytopenia, thrombosis and hemorrhage. Annals of Surgery, 198(3), 301-305.
29. Smythe, M. .A., Stephens, J. L., & Mattson, J. C. (2005). Delayed-onset heparin-induced thrombocytopenia. Annals of Emergency Medicine, 45(4), 417-419.
30. Srinivasan, A. F., Rice, L., Bartholomew, J. R., Rangaswamy, C., La Perna, L., Thompson, J. E., et al. (2004). Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. Archives of Internal Medicine, 164(1), 66-70.
31. Urbankova, J., Quiroz, R., Kucher, M., Goldhaber, S. Z. (2005). Intermittent pneumatic compression and deep vein thrombosis. Thrombosis & Hemostasis, 94(6), 1181-1185.
32. Vandendries, E. R., & Drews, R. E. (2006). Drug-associated disease: Hematologic dysfunction. Critical Care Clinics, 22, 347-355.
33. Warkentin, T. E. (2002). Heparin-induced thrombocytopenia, part 1: The diagnostic clues. Journal of Critical Illness, 17(5), 172-178.
34. Warkentin, T. E. (2002). Heparin-induced thrombocytopenia, part 2: Clinical course and treatment. Journal of Critical Illness, 17(6), 215-221.
35. Warkentin, T. E. (2003). Heparin-induced thrombocytopenia: Pathogenesis and management. British Journal of Haematology, 121(4), 535-555.
36. Warkentin, T. E., & Kelton, J. G. (2001). Delayed-onset heparin-induced thrombocytopenia and thrombosis. Annals of Internal Medicine, 135(7), 502-506.
37. Warkentin, T. E., Maurer, B. T., & Aster, R. H. (2007). Heparin-induced thrombocytopenia associated with fondaparinux. New England Journal of Medicine, 356(25), 2653-2655.